Albacete

Spain

58 total trials 28 recruiting

Filter these 58 trials by phase, condition, sponsor and more.

Open in Search →

Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended recruitment

2023-510390-33-00 5 2020-10-23 HER2-negative breast cancer patients with high relapse risk after stan
Study to evaluate the efficacy of 3 different treatments, followed by maintenance treatment, in older adult patients, between 65 and 80 year … Ended recruitment

2024-516905-22-00 5 2018-10-22 Multiple myeloma
"A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone … Ended recruitment

2024-515368-29-00 5 2012-09-20 patients with node positive breast cancer who do not have high Recurre
A trial in patients with blood cancer and lymphatic system cancer looking at finding the optimal dose of BMF-219 Ended

2024-515744-23-00 1 2023-02-15 Relapsed or refractory (R/R) Acute lymphoblastic leukemia (ALL), R/R A
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran … Ended

2023-503793-20-00 5 2023-01-18 Prevention of ischemic stroke in patients post acute non-cardioembolic
Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants with Relapsed or Refractory Multiple Myeloma (DREAM … Ended

2023-508213-16-00 4 2022-03-15 Multiple Myeloma
Randomised, double-blind, placebo-controlled study to evaluate the effect of metformin, an AMPK activator, on cognitive measures of progress … Ended

2024-518875-73-00 5 2021-12-10 Huntington Disease
A clinical trial with nadunolimab in combination with gemcitabine plus carboplatin in patients with advanced triple negative breast cancer. … Ended

2024-512052-38-00 9 2021-12-02 Advanced triple negative breast cancer
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati … Ended

2023-508472-11-00 5 2018-06-13 Patients with early breast cancer
A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition Ended

2025-520763-41-00 3 Older adults at risk of malnutrition

Showing 49–58 of 58 trials